Investing.com – Merck&Co reported on Thursday first quarter that beat analysts’ forecasts and revenue that topped expectations.

Merck&Co announced earnings per share of $2.14 on revenue of $15.9B. Investing.com polled analyst to predict EPS of $1.83 based on revenue of $15.9B.

Merck&Co shares are up 3% from the beginning of the year, still down 7.65% from its 52 week high of $91.40 set on November 4, 2021. They are outperforming the S&P 500 which is down 12.22% from the start of the year.

Merck&Co follows other major Healthcare sector earnings this month

Merck&Co’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar